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Abstract 
Background: Trimethylation at histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3) controls gene activity dur‑
ing development and differentiation. Whether H3K4me3 and H3K27me3 changes dynamically in response to altered 
microenvironmental conditions, including low‑oxygen conditions commonly present in solid tumors, is relatively 
unknown. Demethylation of H3K4me3 and H3K27me3 is mediated by oxygen and 2‑oxoglutarate dioxygenases 
enzymes, suggesting that oxygen deprivation (hypoxia) may influence histone trimethylation. Using the MCF7 breast 
epithelial adenocarcinoma cell model, we have determined the relationship between epigenomic and transcriptomic 
reprogramming as a function of fluctuating oxygen tension.
Results: We find that in MCF7, H3K4me3 and H3K27me3 marks rapidly increase at specific locations throughout the 
genome and are largely reversed upon reoxygenation. Whereas dynamic changes are relatively highest for H3K27me3 
marking under hypoxic conditions, H3K4me3 occupation is identified as the defining epigenetic marker of transcrip‑
tional control. In agreement with the global increase of H3K27 trimethylation, we provide direct evidence that the 
histone H3K27me3 demethylase KDM6B/JMJD3 is inactivated by limited oxygen. In situ immunohistochemical analy‑
sis confirms a marked rise of histone trimethylation in hypoxic tumor areas. Acquisition of H3K27me3 at H3K4me3‑
marked loci results in a striking increase in “bivalent” epigenetic marking. Hypoxia‑induced bivalency substantially 
overlaps with embryonal stem cell‑associated genic bivalency and is retained at numerous loci upon reoxygenation. 
Transcriptional activity is selectively and progressively dampened at bivalently marked loci upon repeated exposure 
to hypoxia, indicating that this subset of genes uniquely maintains the potential for epigenetic regulation by KDM 
activity.
Conclusions: These data suggest that dynamic regulation of the epigenetic state within the tumor environment may 
have important consequences for tumor plasticity and biology.
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Background
Cancer cells in solid tumors are often exposed to 
repeated cycles of oxygen deprivation and reoxygenation 
that result from inadequate blood supply due to poorly 
developed vasculature [1]. Tumor oxygenation in  situ is 
known to reach very low values, and repeated oxygen 
deprivation and reoxygenation promote tumor stem cell 
properties, metastasis, and negatively affect patient prog-
nosis as adaptive responses to hypoxia severely decrease 
efficacy of both ionizing radiation and chemotherapy 
[2–7]. Hypoxia has also been shown to stimulate repro-
gramming and establishment of induced pluripotent 
stem cells [8–11]. Transcriptional modulation of genes 
involved in glycolysis, angiogenesis, pH homeostasis and 
apoptosis (i.e., anti-apoptotic genes) enables cancer cells 
to adapt to and survive in the hypoxic tumor environ-
ment. Transcriptional changes in hypoxic cancer cells are 
controlled by several well-understood hypoxia response 
pathways [12–14]. Stabilization of HIF1A under low-
oxygen conditions is obtained through interruption of 
prolyl 4-hydroxylase (PHD)-mediated hydroxylation of 
HIF1A and subsequent HIF1A ubiquitylation by the von 
Hippel–Lindau tumor suppressor (pVHL) E3 ligase com-
plex [15–17]. PHDs belong to a larger family of 2-oxog-
lutarate-dependent dioxygenases (2-OGDO), including 
histone demethylases, whose activity is controlled by 
oxygen, iron and 2-oxoglutarate (2-OG; α-ketoglutarate) 
[18–20].
The ability of cells to respond to their microenvi-
ronment is mediated by epigenetic regulatory mecha-
nisms; as such, phenotypic plasticity constitutes a major 
underlying mechanism in development, maintenance of 
homeostasis and cellular diversity [21, 22]. Epigenetic 
control is coordinated at the level of DNA, by (hydroxy)
methylation, RNA, through involvement of regulatory 
noncoding RNAs, and protein, i.a., by (in)activation of 
epigenetic regulators and covalent posttranslational 
modification of histones [23]. Their concerted action 
affects access of transcriptionally regulatory proteins to 
chromatin by nucleosome repositioning, recruitment of 
regulatory factors (i.e., scaffolding factors) and/or altered 
chromatin compaction. These principles also apply to 
other DNA-templated processes, including replication 
and repair [24, 25]. Histone phosphorylation, acetyla-
tion and methylation are examples of covalent chemical 
modifications that occur at the N-terminal tails of core 
histones that constitute the nucleosomal units in chro-
matin [25]. A number of histone trimethylation states, 
among which H3K4me3, are linked to active gene expres-
sion, whereas the relationship between H3K27me3 and 
transcriptional status appears less unambiguous [24, 
25]. H3K27me3 and H3K4me3 states have been inten-
sively studied in the context of transcriptional regulation 
during lineage commitment, cell fate acquisition and 
maintenance during development [26–29]. H3K27 is 
trimethylated by the histone lysine methyl transferases 
(KMTs) EZH2 and EZH1, as part of the Polycomb repres-
sive complex 2 (PRC2) [30, 31]. H3K4me3 marks are 
generated by KMT2A-D (MLL1-4) KMTs that belong 
to the Trithorax Group (TrxG) of epigenetic modifiers 
[32, 33]. Conversely, H3K27 demethylation is carried 
out by the histone lysine demethylases (KDMs) KDM6A 
(UTX) and KDM6B (JMJD3) [34], whereas the KDMs 
KDM5A-D (JARID1A-D) catalyze H3K4 demethylation 
[35]. Although in terminally differentiated cells most 
H3K4me3 and H3K27me3 marks appear mutually exclu-
sive, in embryonic stem cells (ESC) bivalent epigenetic 
marking is believed to prime key developmental control 
genes for context-dependent (in)activation [26–29, 36, 
37]. Current knowledge on the distribution dynamics of 
H3K27me3 and H3K4me3 beyond embryonic develop-
ment is relatively limited.
The Jumonji C-terminal domain histone demethyl-
ases, including the H3K27me3 demethylases KDM6A 
and B, are part of the 2-OGDO family proteins which 
utilize oxygen as a co-substrate during enzymatic 
demethylation [18, 20]. This suggests the possibility 
that histone trimethylation states may be directly cou-
pled to cell oxygenation. Hypoxia has been reported 
to induce global changes in histone methylation and 
is known to induce major transcriptomic changes [38, 
39]. We recently reported that hypoxia causes repres-
sion of DICER through acquisition of H3K27me3 at 
the DICER locus [40]. However, a systematic profiling 
of H3K27me3 and H3K4me3 in relation to oxygen dep-
rivation and the consequences thereof for gene tran-
scription is lacking. We therefore studied the dynamics 
of histone methylation in the context of oxygen dep-
rivation using genome-wide chromatin immunopre-
cipitation followed by deep sequencing (ChIP-seq) and 
combined this with expression microarray analysis in 
MCF7 cells.
We report that the histone H3K27me3 demethyl-
ase KDM6B/JMJD3 is inactivated by limited oxygen 
and show a consequential rapid increase of genomic 
H3K4me3 and H3K27me3 markings in  vitro and 
in  vivo. Acquisition of H3K27me3 at H3K4me3 mark-
ing increases “bivalent” epigenomic marking, which 
displays overlap with embryonal stem cell-associated 
genic bivalency. Hypoxia-induced bivalent marking 
is retained at numerous loci upon reoxygenation and 
selectively and progressively dampens transcriptional 
activity at these loci upon repeated hypoxic exposure 
and reoxygenation, indicating that this subset of genes 
uniquely maintains the potential for epigenetic regula-
tion by KDM activity.
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Results
Increased hypoxia‑induced histone H3 methylation in vivo 
and in vitro
Based on their structural relatedness to 2-OG-dependent 
dioxygenases, we hypothesized that the catalytic activity 
of histone H3K27me3 and H3K4me3 demethylases would 
be inhibited under hypoxic conditions [18, 20]. To deter-
mine whether hypoxia in the tumor environment increases 
histone H3 trimethylation, we established xenografts of a 
human breast cancer cell line and analyzed the spatial rela-
tionship between hypoxia, vascularization and H3K27me3 
and H3K4me3 marks using fluorescence immunohisto-
chemistry. Tumor hypoxia (i.e., pimonidazole uptake) 
showed an inverse correlation with blood vessel density, 
as determined by CD31/PECAM-1 co-staining (Fig.  1). 
Parallel tumor sections stained for pimonidazole and 
H3K27me3 showed enhanced histone H3K27 trimethyla-
tion in hypoxic areas; a merged multi-fluorescence image 
clearly revealed overlap between hypoxia- and H3K27me3-
stained areas within the tumor (Fig. 1). H3K4me3-positive 
cells appeared to be more evenly distributed over the 
tumor compared to H3K27me3 and pimonidazole, yet 
showed good correspondence with pimonidazole-positive 
areas. Thus, both H3K4 and H3K27 trimethylation are 
enhanced in hypoxic tumors.
Human tumors are known to contain cells ranging 
from normal oxygenation to complete anoxia. There is 
strong evidence that transient changes in blood perfusion 
contribute to hypoxia in tumors: Vessel occlusion leads 
to fluctuating oxygen availability in situ (i.e., hypoxia and 
reoxygenation) and can cause complete anoxia of large 
numbers of cells [41]. As low oxygen percentage (<0.05% 
O2) induces significantly more treatment resistance than 
higher oxygen  percentages (>1% O2) in vitro  [42], we set 
out to examine global histone trimethyl states of H3K4 
and H3K27 in MCF7 cells under low oxygen (<0.02% 
O2); to monitor epigenomic effects of fluctuating oxygen, 
H3K4me3 and H3K27me3 levels were also monitored in 
response to reoxygenation (8 h following 24-h hypoxia). 
Increased trimethylation of H3K4 (1.7-fold) and H3K27 
(2.2-fold) was detectable within 8 h of hypoxia and was 
sustained until 24-h hypoxia (Fig. 2a). Conversely, upon 
restoration of oxygenation, global histone H3K4 and K27 
trimethylation returned to baseline at approximately 
12–24  h after reoxygenation (Fig.  2a; Additional file  1: 
Fig. S1A). Similar H3K27me3 dynamics were observed 
in an independent cancer cell line (Additional file 1: Fig. 
S1A). Altered H3K9/K14 acetylation status is consistent 
with an earlier report [39], yet appears to be cell context 
specific (Additional file 1: Fig. S1A).
To test the dependency of KMD6B activity on oxygen, 
we measured H3K27me3-directed demethylase activ-
ity in  vitro as a function of oxygen concentration using 
purified recombinant KDM6B protein. H3K27 tri-dem-
ethylase activity sharply declined from 100% at ambient 
oxygen levels to 20% activity at 5% oxygen (Fig.  2b). A 
near linear correlation between oxygen level and enzy-
matic activity was observed within a physiological range 
of oxygen pressure (5–1–0.2%). No KDM activity was 
observed below 0.2% oxygen.
To determine whether the increased H3K4me3 and 
H3K27me3 levels during hypoxia could be explained by 
changes in expression of corresponding KMTs, we deter-
mined mRNA and protein expression levels of a number 
of these epigenetic regulators in the context of hypoxia/
reoxygenation. Overall, mRNA levels of most confirmed 
and putative H3K4- and/or H3K27-directed HMTs were 
low and not substantially affected by altered oxygen pres-
sure within the time frames examined (Additional file 1: 
Fig. S1B). Correspondingly, protein levels of MLL1/
KMT2A, MLL4/KMT2B and SETD1A/KMT2F did not 
change appreciably in response to oxygen deprivation 
(Additional file 1: Fig. S1D). Expression of the H3K27me3 
HMT-encoding gene EZH2 decreased in response to oxy-
gen deprivation (Additional file 1: Fig. S1B). In contrast, 
expression of a number of relevant KDM encoding genes, 
including KDM5B and KDM6B, showed a slight increase 
in hypoxic cells (Additional file 1: Fig. S1C). Protein levels 
of EZH2 and KDM6B in MCF7 cells followed the mRNA 
expression profile throughout the experiment. EZH2 
protein levels decreased under hypoxia, whereas KDM6B 
protein levels remained unchanged under hypoxic con-
ditions and dropped upon reoxygenation (Additional 
file  1: Fig. S1D). Hence, the change in expression lev-
els for both the writer and eraser for the H3K27me3 
could not account for the observed global increases in 
H3K27me3 marks. To explore the possibility that EZH2 
activity contributes to increased H3K27me3, MCF7 cells 
were exposed to hypoxia in the presence or absence of 
pharmacological inhibitors of EZH2 (EZHi). Reduced 
normoxic H3K27me3 levels confirmed pharmacological 
inhibition (Additional file  1: Fig. S1E). Relevantly, how-
ever, H3K27me3 levels remain reproducibly higher under 
hypoxic conditions in the presence of EZHi, compared 
to normoxic/EZHi conditions. These data are consistent 
with the notion that global H3K27me3 increases under 
hypoxic condition despite EZH2 inhibition (Additional 
file  1: Fig. S1E). Taken together, these findings suggest 
that physiological levels of hypoxia, including those com-
monly found in solid tumors, negatively affect histone 
demethylation activity.
Selective acquisition of histone methylation at genic 
regions
We next determined whether changes in oxygen regu-
late epigenetic states at specific genetic sites. To this end 
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ChIP-seq analysis was performed for both H3K4me3 
and H3K27me3 in normoxic (t  =  0), hypoxic (t  =  8 
and 24  h) and reoxygenated cells (t = +8  h). ChIP-seq 
analysis confirmed enhanced global trimethylation of 
H3K4 and H3K27 in response to hypoxia, consistent 
with the immunoblotting findings. The total number of 
H3K4me3- and H3K27me3-marked genomic regions, 





Fig. 1 Tumor hypoxia increases trimethylation at H3K4 and H3K27. Representative images of whole tumor parallel sections stained for pimo‑
nidazole (hypoxia marker, red) and CD31 (PECAM‑1; endothelial cell surface marker, green; upper left), H3K27me3 (red) and CD31 (green; upper 
right), H3K4me3 (red) and CD31 (green; lower left); scale bar represents 1 mm. The color‑merged image (lower right) shows pimonidazole (green) and 
H3K27me3 (red). Captions show enlargements of the indicated areas; scale bar represents 100 µm
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1.2-fold, respectively, at 24-h hypoxia (Fig.  2c, d, upper 
panels; Additional file  1: Fig. S2A, B). Representative 
genome tracks illustrate examples of genes that dis-
played hypoxic gain of H3K4me3 or H3K27me3 levels 
in response to reduced oxygenation (Fig.  2c, d, lower 
panels). Bioinformatic calling of enriched regions was 
validated by ChIP-PCR for a number of representative 
epigenetic profiles (e.g., H3K4me3- or H3K27me3-only 
marking, H3K4me3 or H3K27me3 gain; Additional file 1: 
Fig. S2C). The same data set was used to show that both 
marks had quantitatively increased at all decorated gene 
regions (data not shown) [43]. These findings show that 
hypoxia causes an overall reversible epigenome-wide 
increase of H3K4me3 and H3K27me3, and establish that 
oxygen is required for constitutive activity of KDM and 
maintenance of the basal epigenetic state of a large num-
ber of genomic regions.
To further enhance comparative epigenomic, enriched 
sequences were segregated into genic (i.e., “genes” 
±5000  bp) and intergenic regions. Under normoxic con-
ditions, trimethylation was highly associated with genic 
regions: more than 84% of all H3K4me3 peaks located to 
genes, compared to 41% for H3K27me3 peaks (Fig. 2c, d). 
Intergenic H3K4me3 association showed a relative increase 
as a result of acute oxygen deprivation (16% at t  =  0 to 
34% at t = 8 h; Additional file 1: Fig. S3A), while intergenic 
H3K27me3 association did not change significantly (59% at 
t = 0 to 55% at t = 8 h; Additional file 1: Fig. S3B).
In normoxic cells, approximately 46% of all genes 
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Fig. 2 Reversible, oxygen‑dependent global changes of H3K4me3 and H3K27me3 levels. a Immunoblot detection (IB) of epigenetic changes 
(H3K4me3 and H3K27me3) in MCF7 cells; loading control: total H3 (H3); lower panel quantification. b Ability of recombinant JMJD3 to demethyl‑
ate H3K27me3 peptide in vitro was determined at 0.02, 0.2, 1, 5 and 21% (ambient) partial O2 pressure; EDTA was used as a negative control as it 
blocks JMJD3 activity. Number of peaks for H3K4me3 (c) and H3K27me3 (d) significantly above background level (p < 0.05) at different time points 
under hypoxic conditions (t = 8, t = 24 h) and after reoxygenation (t = +8 h). Bottom panels to c and d: representative gene tracks of loci displaying 
H3K4me3 gain (ATP2A3, GPRC5B) or H3K27me3 gain (CYP1B1, OPRL1); diamond symbol indicates direction of gene transcription
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only 9% carried H3K27me3 marks (n  =  1968) (Fig.  3a, 
d). The number of H3K4me3-marked genes increased by 
approximately 16 and 20% after 8 and 24  h of hypoxia, 
respectively (Fig.  3a). The relative change of H3K27me3 
was significantly higher with increases of ±80 and 50% 
at 8 and 24  h of hypoxia, respectively (Fig.  3d). To pro-
file the hypoxia-induced enrichment of H3K4me3 and 
H3K27me3 within genic regions, enrichment data were 
visualized using transcription start site (TSS)-centered 
plots. Under normoxic conditions, H3K4me3 was promi-
nently enriched around the TSS with a distinctive deple-
tion directly over the TSS; this finding is consistent with 
earlier reports showing reduced nucleosome presence 
at this site (Fig.  3b) [44]. In sharp contrast, H3K27me3 
marking at normoxia coincided mainly within gene body 
enrichment, consistent with the reported “blanketing” 
enrichment of H3K27me3 (Fig. 3e) [43, 45, 46]. Of note, as 
nearly half of all genes were H3K4me3-enriched already 
under normoxic conditions (cf. Fig.  3b) and H3K27me3 
enrichment was substantially increased (cf. Fig.  3e), 
hypoxia-induced global H3K27 trimethylation enhanced 
the frequency of bivalently marked genes (see below).
Reoxygenation nearly fully restored the intergenic–
genic ratio of the H3K4me3 peak distribution to that 
initially observed at ambient oxygen levels (16% at t = 0; 
18% at t = +8; Fig. 2c; Additional file 1: Fig. S3A). Genic 
enrichment of H3K27me3 was relatively sustained (41 vs. 
53%; Fig.  2d; Additional file  1: Fig. S3B). The TSS-cen-
tered H3K4me3-enrichment profile did not significantly 
change as a result of hypoxia or reoxygenation (Fig. 3b), 
whereas selectively enhanced H3K27me3 enrichment 
over and around the TSS was partially retained dur-
ing reoxygenation (Fig.  3e). Combined, the in  vitro and 
in  vivo findings support increased overall histone tri-
methylation at H3K4 and H3K27 under hypoxia and 
suggest that H3K27me3 marking showed the relatively 
highest dynamic change under hypoxic conditions.
Normoxic H3K4me3 and H3K27me3 marking dictate gene 
activity under hypoxia
To correlate H3K4 and H3K27 trimethylation to gene 
activity, total RNA samples were collected for analysis at 
all time points in parallel and ChIP-seq data were com-
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Fig. 3 Histone methylation profiles at genic regions during hypoxia. a Bar graph depicting numbers of H3K4me3‑associated genes under indicated 
conditions (normoxia: 0 h, acute hypoxia: 8 h; chronic hypoxia: 24 h; reoxygenation: +8 h); b H3K4me3 peak intensity density distribution proximal 
to the TSS in relation to oxygen deprivation and reoxygenation; c Boxplots representing median gene expression in relation to H3K4me3 marking. 
d Bar graph depicting numbers of H3K27me3‑associated genes; e H3K27me3 distribution proximal to the TSS in relation to oxygen deprivation 
and reoxygenation; f Boxplots representing median gene expression in relation to H3K27me3 marking. Data presented reflect indicated conditions 
(normoxia: 0 h, acute hypoxia: 8 h; chronic hypoxia: 24 h; reoxygenation: +8 h). Asterisks (c, f) indicate statistically significant differences (p < 0.05)
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exposure. Gene Ontology (GO) classification confirmed 
regulation of expected processes in response to hypoxia 
(Additional file  2: Table S1), consistent with published 
data [38]. H3K4me3-marked genes were significantly 
higher expressed at all individual time points (Fig.  3c), 
whereas H3K27me3-marked genes showed substantially 
lower median gene transcript levels compared to non-
marked genes (Fig. 3f ). Relevantly, within a subset of pre-
viously reported HIF1A target genes [47], 97.5% showed 
increased transcriptional activity (Additional file  2: Fig. 
S4A). Relevantly, the number of H3K4me3-marked 
HIF1A target genes was increased in hypoxic MCF7 cells 
(Additional file 1: Fig. S4B). Thus, consistent with expec-
tation, oxygen deprivation induced HIF1A-dependent 
transcription. To examine whether hypoxia-induced 
HIF1A regulation directly affected global H3K4me3, 
H3K4me3 levels were also measured in the absence of 
HIF1A. This analysis showed that global H3K4me3 lev-
els increase under hypoxic conditions, irrespective of 
the presence or absence of HIF1A (Additional file 1: Fig. 
S4C). Thus, HIF1A-mediated stress responses do not sig-
nificantly contribute to global enhancement of H3K4me3 
marking under these conditions.
We next aimed to correlate the specific intragenic loca-
tion of H3K27me3 marks to gene expression and deter-
mined the effect of gain or loss of these trimethyl marks 
on transcriptional regulation at all time points. Overall, 
more gene transcripts were down-regulated than up-
regulated in response to hypoxia: Of all expressed genes 
approximately 58–59% showed reduced transcript levels 
(Additional file 1: Fig. S5A–C). We then assigned genes 
to one of three previously defined H3K27me3-enrich-
ment profiles at all experimental time points [48]: (1) a 
distinct H3K27me3 peak upstream of the TSS (promoter 
profile; −3000/−100  bp with respect to TSS), (2) a dis-
tinct peak at the TSS (TSS profile; −100/+1000 bp), and 
(3) no single peak, but instead a “blanketed” distribu-
tion over the gene body typical of Polycomb-mediated 
repression (broad profile; +1000/last exon). In control 
(i.e., normoxic) samples more than half of all H3K27me3-
marked genes displayed the broad enrichment profile, 
whereas the TSS and promoter profiles were equally rep-
resented (Fig. 4a, cf. Additional file 1: Fig. S3B). Hypoxia 
predominantly increased TSS-directed H3K27me3 
marking; this relative distribution was maintained for 
the duration of the hypoxic condition (Fig. 4a, b). Gene 
expression measurements were plotted for each indi-
vidual profile and compared to the overall expression of 
all H3K27me3-enriched genes and non-marked genes. 
Distinctive TSS marking and gene body enrichment con-
sistently correlated with low gene expression/repression 
under normoxic and hypoxic conditions (Fig. 4c). In con-
trast, promoter H3K27me3 enrichment was associated 
with a significantly higher median gene expression level 
compared to the total H3K27me3-marked gene popula-
tion, under both normoxic and hypoxic conditions, and 
equaled or exceeded expression levels of non-marked 
genes. H3K4me3 enrichment at H3K27me3-marked 
genes correlated with a higher median expression level, at 
normoxic or hypoxic conditions (Fig. 4d; gray boxplots). 
This effect was strikingly evident for promoter-marked 
and to a lesser degree for broad H3K27me3-marked loci. 
In contrast, the presence of H3K4me3 at H3K27me3 
TSS-marked genes had relatively little effect on median 
gene expression levels (Fig.  4d). Thus, TSS-directed 
H3K27me3 marking correlates with relative transcrip-
tional repression, independent of H3K4me3 status. In 
contrast, the additional presence of H3K4me3, particu-
larly at promoter-marked and broad H3K27me3-marked 
loci, correlates with higher gene transcription, irrespec-
tive of oxygenation status.
To determine the consequences of hypoxia-induced 
epigenetic modulation on transcriptional status, loci 
were first categorized based on their enrichment pro-
file under normoxic conditions (i.e., H3K4me3-only, 
H3K27me3-only, double-marked or non-marked; Addi-
tional file  1: Fig. S6A;a–d). Out of all genes that were 
single H3K4me3-marked under normoxic conditions, 
90% showed persistent H3K4me3 marking and remained 
transcriptionally active well into hypoxia (t  =  8, 24  h; 
Additional file  1: Figs. S6B;a and S6C;a, respectively). 
H3K4me3-marked genes that gained H3K27me3 mark-
ing maintained their median expression level (“H3K4me3 
and H3K27me3”; t =  8, 24  h hypoxia; Additional file  1: 
Fig. S6B–C;a). Loss of H3K4me3 (i.e., conversion to 
H3K27me3-only or non-marked at t = 8, 24 h) occurred 
at relatively few loci; activity status of such loci was low 
already at t = 0 (Additional file 1: Fig. S6B–C;a). Median 
expression at H3K27me3 single-marked loci was con-
sistently lower compared to loci in the three other cat-
egories, independent of whether the H3K27me3 mark 
was already present at normoxic conditions (Additional 
file 1: Fig. S6B–C;b) or it was acquired upon oxygen dep-
rivation (Additional file  1: Fig. S6B–C;a,d). H3K27me3-
only marked genes (at t =  0) showed a relatively strong 
shift toward gain of H3K4me3 under hypoxic conditions 
(±30–50%; Additional file  1: Fig. S6A–C;b). Genes that 
carried both trimethyl marks at t =  0 showed an inter-
mediate median expression level compared to H3K4me3-
enriched (high expression) and H3K27me3-marked 
or non-marked genes (low/no expression) (Additional 
file 1: Fig. S6B;c). Approximately 15% of double-marked 
genes lost either H3K4me3 or H3K27me3 enrichment 
in response to acute oxygen deprivation; loss of either 
trimethyl mark did not affect median expression levels 
(n = 123/t = 8 and 151/t = 24, respectively; Additional 
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file 1: Fig. S6B–C;c). Of all non-trimethyl-marked genes 
at t  =  0, the majority (>80%) retained this epigenetic 
status until 24 h of hypoxia (Additional file 1: Fig. S6A–
B;d). Finally, acquisition of either single H3K4me3 or 
combined trimethyl marks did not affect median tran-
scription activity at originally H3K27me3 single- or 
non-marked loci, respectively (Additional file  1: Fig. 
S6B–C;b,d).
Although the repression-associated TSS H3K27me3 
peak intensity distribution was partially maintained upon 
reoxygenation (cf. Fig.  3e), the correlation between TSS-
H3K27me3 marking and transcriptional repression at 
H3K4me3 and H3K27me3 double-marked loci was lost 
(Fig.  4c, d; Additional file  1: Fig. S6D;c). Comparable 
dynamics applied to broad H3K27me3-marked loci. The 
increased median expression in response to acute reoxy-
genation (cf. Fig.  3f) suggested (temporary) functional 
uncoupling of epigenetic marking and transcriptional regu-
lation. In line with this notion, GO classification indicated 
that numerous cellular processes, including some with no 
direct relevance to MCF7/breast epithelium biology, were 
affected by reoxygenation (Additional file 2: Table S3).
Taken together, comparative analysis of altered intra-
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Fig. 4 Transcription status is primarily controlled by H3K4me3. a Bar graphs depicting numbers of H3K27me3‑marked genes at indicated experi‑
mental conditions (normoxia: 0 h, acute hypoxia: 8 h; chronic hypoxia: 24 h; reoxygenation: +8 h): H3K27me3‑enriched loci were classified as (upper 
to lower panels): all H3K27me3‑enriched genes (All categories), promoter (Promoter)‑, transcription start site (TSS)‑ and gene body (Broad)‑marked 
genes; b TSS‑associated enrichment profiles (average number of reads) for the corresponding H3K27me3 classes (colored lines; solid: promoter, 
dashed: TSS, dotted: broad profile) represent all H3K27me3‑marked genes. c Boxplots: H3K27me3 enrichment was plotted against median expres‑
sion levels. Comparative analysis was done at (upper to lower panels) t = 0, t = 8, t = 24 h hypoxia and after reoxygenation (t = +8 h). Subscripts 
correspond to non‑marked (no mark), all H3K27me3‑marked genes (all), and to promoter, TSS and broad H3K27me3 profiles as indicated. d Boxplots: 
H3K4me3 + H3K27me3 and H3K27me3 enrichment only were plotted against median expression levels. Comparative analysis was done at (upper 
to lower panels) t = 0, t = 8, t = 24 h hypoxia and after reoxygenation (t = +8 h). Subscripts correspond to non‑marked (no mark), all H3K27me3‑
marked genes (all), and to promoter, TSS and broad H3K27me3 profiles as indicated; gene numbers are indicated in insets. Asterisks (c, d) indicate 
statistically significant differences (p < 0.05)
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that H3K4me3 status is the main determinant of tran-
scriptional activity, under both oxygenated and oxygen-
deprived conditions.
Hypoxia‑induced epigenetic bivalency overlaps 
with bivalent genes in ES cells
Based solely on co-occurrence of H3K4me3 and 
H3K27me3 marks within genic regions, more than 800 
genes were classified as bivalently marked under nor-
moxic conditions; the number of double-marked genes 
had increased threefold (821 genes, t = 0–2200, t = 24 h) 
as a result of hypoxia. To obtain proof that H3K4me3 
and H3K27me3 occur within the same allele and are not 
merely a reflection of different cell pools, bivalent mark-
ing was confirmed by sequential ChIP (i.e., ChIP/re-
ChIP) at a number of loci (Additional file 1: Fig. S7).
The original epigenetic status of loci that had acquired 
bivalent marking (at t  =  8  h hypoxia) was traced back 
to that under normoxic conditions and displayed as a 
function of experimental oxygenation condition. More 
than half (55%, 1297 genes) of bivalently marked genes 
had acquired H3K27me3 alone or in combination with 
H3K4me3 at 8  h (Fig.  5a, b). Acquisition of bivalency 
by gain of H3K4me3 under hypoxic conditions revealed 
a bias toward TSS H3K27me3-marked loci: Of all TSS/
H3K27me3-marked genes, 36% was already bivalently 
marked at t =  0; the number of bivalently TSS-marked 
loci increased ±5.3-fold (at t = 8) (Additional file 1: Fig. 
S8A). Gene body (broad) H3K27me3-enriched genes 
showed a relatively lower H3K4me3-gain compared to 
the TSS profile (38% H3K4me3-marked at t =  0; ±2.9-
fold increase at t  =  8). Promoter/H3K27me3-marked 
loci appeared underrepresented with regard to acqui-
sition of bivalency: Due to preexistent TSS/H3K4me3 
marking at many loci, the relative increase of bivalent 
promoter-marked genes was comparatively small under 
hypoxic conditions (62% of promoter-H3K27me3 genes 
were H3K4me3-marked at t  =  0, ±1.3-fold change in 
gene numbers at t = 8). Thus, increased bivalent marking 
under hypoxic conditions is mainly the result of gain of 
H3K27me3.
Although bivalency was lost at a substantial percentage 
of loci upon reoxygenation (68% compared to t =  24  h 
hypoxia), bivalent epigenetic marking persisted at more 
than 1600 loci (approximately twofold higher compared 
to normoxia), whereas gain of a single mark was lost 
upon reoxygenation (Fig.  5b). The stability of acquired 
bivalency suggests that bivalent H3 trimethylation is rela-
tively resistant to KDM activity at these loci.
Bivalently marked loci are often found among key 
developmental control genes in (embryonic) stem/pro-
genitor cells [26, 28, 29, 36, 37]. We tested whether the 
hypoxia-induced bivalently marked gene set in MCF7 
cancer cells showed overlap with bivalent genes previ-
ously identified in ESC. Approximately 12–25% of the 
1500–1700 hypoxia-induced bivalent genes in MCF7 
cells overlapped previously identified trimethylated 
genes in ESC [28, 49]; this match between bivalently 
marked genes in MCF7 and ES cells increased under 
hypoxia (Fig. 5c) and was, as described above, relatively 
sustained under reoxygenation (cf. Additional file 1: Fig. 
S8A). Comparative GO analysis of both bivalent gene 
pools revealed a distinctive overlap of functional path-
ways involved and confirmed the presence of bivalently 
marked developmental genes; in addition, a number of 
GO terms (i.a. anti-apoptosis, cell migration, angiogen-
esis) suggested relevant processes in the context of pro-
gressive malignancy (Additional file  2: Table S3). Many 
of these genes were already bivalently marked at the 8-h 
hypoxia time point, suggesting that these loci are preset 
targets for bivalent marking under low oxygen. Hence, 
our findings suggest that oxygen deprivation in breast 
cancer cells induces bivalent epigenetic marking at genes 
which are also bivalently marked in ESC and which con-
trol key processes during development.
Transcriptional activity at bivalently marked loci in 
ESC is known to be low [26, 28, 29, 36]. To determine 
the consequences of acquired bivalent marking for tran-
scriptional activity, specifically in the context of reoxy-
genation, we retrospectively traced the expression status 
of a set of loci that gained bivalent marking (H3K4me3/
gain-H3K27me3) during hypoxia and had retained this 
epigenetic status upon reoxygenation. As more than 
85% of these genes showed a relatively low expression 
level at t  =  0 (i.e., between 3.68 and 6.64 log2-based 
expression values), we compared these genes to a set of 
stable H3K4me3-only marked genes that had a compara-
bly low median expression level at t =  0, but remained 
H3K27me3-free under hypoxic conditions. H3K4me3-
only marked genes showed a clear and significant pro-
gressive reduction of median transcriptional activity 
under hypoxia and a nearly complete restoration to 
original (t = 0) median expression level upon reoxygena-
tion (Additional file  1: Fig. S8B). In contrast, transcrip-
tional activity at H3K4me3/gain H3K27me3 bivalently 
marked loci did not significantly change between time 
points, but instead showed a trend toward a steadily 
reduced median expression which was maintained upon 
reoxygenation (Additional file 1: Fig. S8B). This observa-
tion suggested that a subset of genes that acquires and 
retains a bivalent epigenetic state, has selectively main-
tained responsiveness to transcriptional regulation by 
H3K27 trimethylation. To test the idea that repeated 
cycles of hypoxia/reoxygenation induce a progressive 
reduction of transcriptional activity at these loci, cells 
were exposed to either 6 or 18 relatively short cycles of 
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hypoxia/reoxygenation, as they would occur in tumors [2, 
41]. Expression of 5 randomly chosen genes represent-
ing each of both categories (i.e., low expression and t = 0, 
and H3K4me3-only or H3K4me3/gain-H3K27me3) was 
analyzed by rtPCR. Relevantly, 4 out of 5 bivalent mark-
ers showed a significant reduction of transcriptional 
activity (1 marker showed no significant change; data not 
shown), whereas H3K4me3-only marked loci showed 
either increased (3/5) or unchanged (2/5; one marker not 
shown) expression levels compared to t = 0 (Fig. 5d).
These collective findings suggests that oxygen depriva-
tion induces epigenetic bivalency in MCF7 cancer cells, 
Incubation time (hrs)


























































































































































Fig. 5 Hypoxia increases genic bivalent marking. a Bar diagrams depicting increased bivalency (gene numbers) by gain of H3K4me3 (green), gain 
of H3K27me3 (red) or gain of both H3K4me3/H3k27me3 marks (orange) during hypoxia and reoxygenation. Gray color bars indicate the number of 
bivalent marked genes already present at the indicated time points. b Bar graphs showing relative changes of H3K4me3‑mono, H3K27me3‑mono 
and bivalent marking at the indicated time point. c Bar graph depicting percentage match of bivalently marked genes in MCF7 cells (at different 
experimental time points) and in ESC. Comparison of bivalently marked MCF7 loci with published data sets revealed 11–13% (reference data set: 
[28]; data not shown) to 25% target overlap (reference data set: [49]). d Bar graph depicting changes in expression levels of bivalently marked (4 
genes: ARRB1, ADCY5, AKAP1, FAM217B; representing a total of n = 225) and H3K4me3‑only marked (4 genes: ASB8, RPL31P17, LRRC28, PPAT; repre‑
senting a total of n = 5755) genes under the indicated experimental conditions. Gene categories were defined based on low expression levels at 
t = 0 (log2‑based expression value 3.68–6.64). Normoxic expression values (t = 0; left‑most, gray bars) were set to 1; orange bars represent transcrip‑
tional activity at the indicated H3K4me3/gain H3k27me3 markers at 24‑h chronic hypoxia (24), 6 (6c) or 18 (18c) cycles of oxygen deprivation/reoxy‑
genation; green bars represent transcriptional activity at the indicated H3K4me3‑only marked loci (24 h, 6c, 18c). Marker expression was normalized 
to the geo‑mean of beta-actin and cyclophilin A. Asterisks indicate statistical significant differences as depicted in the figure; ns nonsignificant 
difference
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which correlates best with a TSS-specific increase of 
H3K27me3 at H3K4me3 premarked (i.e., at t = 0) genes, 
and that this acquired epigenetic status is selectively 
maintained upon reoxygenation despite global loss of tri-
methylation. In addition, the data suggest that acquired 
bivalent marking is relatively stable and prevents tran-
scriptional variability during hypoxia and reoxygena-
tion at a select set of genes that overlap with bivalently 
marked genes in ESC.
Discussion
Here, we report that hypoxia, through enzymatic inhi-
bition of KDMs, increases histone H3 trimethylation in 
cultured MCF7 breast cancer cells and in breast cancer 
xenografts. Although most changes in H3K4me3 and/
or H3K27me3 levels are transient and return to base-
line levels upon reoxygenation, we provide evidence that 
some H3K27me3 enrichment persists at defined genomic 
regions. During hypoxia increased histone trimethylation 
leads to acquisition of bivalent marking at numerous loci 
and transcriptional activity at these loci is stably main-
tained at a low level with a trend toward reduced expres-
sion relative to H3K4me3-only marked loci. As a subset 
of these bivalently marked genes represents previously 
identified bivalently marked genes in ESC, these findings 
suggest a link to tumor cell plasticity and/or stemness.
Hypoxia‑induced reversible histone trimethylation
Comprehensive insight into transcriptional reprogram-
ming in response to changing microenvironments 
requires systematical genome-wide mapping of epige-
netic marks as a function of cell type, differential state 
and microenvironment [24]. We here studied dynamic 
changes in histone trimethylation in the context of cellu-
lar adaptation to changes in oxygenation status (hypoxic 
stress, reoxygenation). We were able to reproduce the 
reported correlation between gene body-associated 
“blanketing” H3K27me3 profile and transcriptional 
repression, thereby validating our analytical approach 
[43]. The prominent TSS-centered H3K4me3 enrichment 
at expressed loci and the marked low nucleosome abun-
dance right over the TSS are also consistent with earlier 
findings [27].
Increased global histone trimethylation during hypoxia 
could theoretically result from increased histone methyl 
transferase activity or reduced histone demethylase activ-
ity. In line with the original hypothesis that 2-OGDO 
family proteins to which the Jumonji class of KDMs 
belong, depend on molecular oxygen for their activity, we 
provide direct evidence that KDM6B activity is inhibited 
under hypoxic conditions. The steep decline of global 
H3K4me3 and H3K27me3 levels following reoxygenation 
is likely to be due to increased KDM protein expression 
during the course of hypoxic treatment and rapid KDM 
activation by molecular oxygen. By inference, inhibition 
of KDMs in the absence of molecular oxygen is likely to 
be responsible for the increased TSS-directed bivalency. 
This finding implies that maintenance of the epigenetic 
status at these genes under basal (i.e., normoxic) condi-
tions likely requires continuous dynamic remodeling by 
KDMs, among other enzymes, and that such loci may 
be uniquely sensitive to specific signals from the micro-
environment (e.g., cofactor availability). Although the 
involvement of demethylases was recently addressed 
in the context of hypoxia-induced increased H3K4me3 
marking [50], our studies provide additional insight into 
the effects of reoxygenation on epigenomic and tran-
scriptomic responses. Our combined observations thus 
establish that oxygen sensing by KDM represents a direct 
link between the microenvironment and epigenetic regu-
latory mechanisms.
Hypoxia‑induced epigenetic changes versus gene 
expression
Our comparative analysis of ChIP-seq and expres-
sion array data sets revealed a clear positive correlation 
between TSS-directed H3K4me3 enrichment and gene 
expression under all conditions. H3K27me3 displayed 
multiple distinct genic enrichment profiles, in line with 
previous publications [48, 51]. H3K27me3 enrichment 
across the gene body (broad profile) followed the classical 
Polycomb-associated repressive H3K27me3-enrichment 
profile, which is referred to as “blanketing” [45, 46]. Thus, 
the strong promoter/TSS association of genic H3K4 tri-
methyl marking versus the clear gene body-directed 
genic H3K27me3 marking demonstrate that genomic 
decoration with H3K4me3 and H3K27me3 is consistent 
with their known distribution and roles in gene regula-
tion. In addition, the selective changes in genic marking 
indicate that increased H3 trimethylation during hypoxia 
is not occurring in a random fashion.
Sustained H3K4me3 marking upon hypoxic treatment 
appears epigenetically dominant over genic H3K27me3 
acquisition in regard to transcriptional regulation. 
Although a possible involvement of altered RNA stabil-
ity can formally not be excluded, transcriptional changes 
should in principle be detectable over the time inter-
vals in our experimental setting (e.g., gain of H3K4me3 
showed a positive trend with increased expression). The 
exact relevance of Polycomb repressive complex-asso-
ciated (PRC) H3K27me3 marking and enrichment at 
different intragenic positions is currently not fully under-
stood. The H3K27me3 mark is bound by both PRC1 and 
PRC2 proteins; these interactions are likely important for 
reestablishment and thus transfer of an epigenetic state 
[52–57]. H3K27me3-dependent target-gene silencing 
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can act via distant enhancer-looping to gene promoters 
in insect and in mammalian systems [58]. However, PRC 
proteins are known to localize at active RNA polymerase 
2 (POLR2) promoters in Drosophila and to interact with 
basal transcription factors (TF) [59]. In keeping with this 
notion, we recently showed that transcriptional activa-
tion at a defined PRC1-target locus did not require loss of 
H3K27me3 marking, but PCR1/chromatin dissociation 
[60]. In addition, PRC associates with splicing factors, 
revealing an as of yet poorly understood additional role 
in regulation of gene expression [61]. Hence, our obser-
vations herein suggest that, once marked for transcrip-
tion, acquisition of genic H3K27me3 marking may not 
be sufficient for transcriptional repression per se, but is 
likely to depend on additional (epigenetic) events.
Implications of increased bivalency under hypoxia
We show that a subset of H3K4me3-marked genes 
acquired bivalency principally by gain of TSS-directed 
H3K27me3 marking relative to promoter and gene body 
marking; this resulted in bivalent marking of a substantial 
number of genes (±950–1100; at t = 8 and 24 combined). 
Despite the global demethylation following reoxygena-
tion, bivalent marking persisted at a substantial number 
of loci 8  h into restoration of oxygen levels. Co-occur-
rence of both methyl marks was first described in embry-
onic stem cells and is thought to mark key developmental 
control genes as “poised” for transcriptional activation. 
Specific H3K27me3 enrichment at promoter regions, 
in combination with a marked depletion of gene body-
directed H3K27me3 marking, overlaps with H3K4me3-
enrichment profiles and appears permissive for active 
transcription; such bivalently marked genes are typically 
expressed at low levels in stem cells [26, 28, 29, 36, 37, 
45]. Interestingly, the bivalent gene subset in hypoxic 
MCF7 cells represents a substantial number of genes pre-
viously identified as bivalently marked genes in ESC.
We observed that within the bivalently marked subset, 
TSS-directed H3K27me3 acquisition with preexistent 
H3K4me3 marking dampened transcriptional fluctua-
tion of the corresponding genes compared to H3K4me3-
only marked genes. Relevantly, upon repeated exposure 
to hypoxia, as would occur in tumor cells in  situ [2], 
transcriptional activity was significantly and specifically 
reduced at these bivalent loci. This finding strongly sup-
ports the notion that transcriptional activity at these loci 
is specifically controlled by H3K27me3 demethylases and 
that such loci may also be sensitive detectors of oxygen 
and other KDM cofactor availability. Of relevance, KMTs 
(e.g., for H3K4me3) are often found in close conjunction 
with KDMs for functionally opposing epigenetic marks 
(e.g., H3K27me3); together these paired epigenetic mod-
ulators are thought to reinforce transcriptional decisions, 
a concept termed: co-stability [62]. It is tempting to 
speculate about a similar role for cooperativity between 
H3K4me3 KMTs and H3K27me3 KDMs in the establish-
ment of bivalency under KDM-inhibitory conditions, as 
our findings identify a subset of genes which is appar-
ently preset for acquisition of bivalent marking; tran-
scriptional activity at these loci is likely to be specifically 
controlled by H3K27me3 KDM. It is currently unclear 
whether and how these loci are protected from KDM 
activity (and/or KMTs) upon reoxygenation, although 
it is conceivable that some other local epigenetic aspect 
(e.g., inhibitor recruitment or higher-order chromatin 
structure) mediates sustained methylation status. Irre-
spective of the exact underlying mechanism, our findings 
identify the H3K27me3 mark as most prone to dynamic 
change in response to hypoxia/reoxygenation and define 
a novel role for oxygen in epigenetic regulation of stress 
responses.
Hypoxia, epigenetics and cancer
Although the relevance of reduced gene expression at any 
of the select bivalent loci in regard to (tumor) stemness 
is currently unknown, numerous reports support a con-
nection between hypoxia and stem cell biology. Stem 
cell niches are known to be hypoxic [63–66]. Hypoxia 
enhances iPSC formation in vitro [8–11]. Repeated oxy-
gen deprivation and reoxygenation are known to pro-
mote tumor stem cell properties, metastasis, and patient 
prognosis and adaptive responses to hypoxia severely 
decrease efficacy of both ionizing radiation and chemo-
therapy [3–5]. We have recently shown that oxygen with-
drawal results in the acquisition of stem cell phenotypes 
in human mammary epithelial cells via inhibition of oxy-
gen-dependent H3K27me3 demethylases KDM6A/B and 
consequential reduction of DICER expression and dere-
pression of the miR-200 target ZEB1 [40]. Our combined 
findings suggests that whereas increased H3K27me3 dec-
oration under hypoxic conditions is an epigenome-wide 
event, it is likely not sufficient for acquisition of stemness 
like properties, as sphere-forming capacity appears to be 
a stochastic event [40]. As cancer development is thought 
to be sustained by cancer stem cells [67–69], it is tempt-
ing to speculate about a possible role for bivalent marking 
in re-establishing a “poised” gene status, and that hypoxic 
microenvironment selects for or drives tumor plasticity 
through acquisition of a less differentiated epigenome.
Conclusions
Our understanding of altered chromatin states and the 
role of epigenetic modifiers in the context of embryogen-
esis, spermatogenesis, metabolic disorders and tumori-
genesis has progressed rapidly [70, 71]. Recent advances 
have implicated mutation and/or dysregulated expression 
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of KMTs and KDMs in cancer. Identification of muta-
tions and deregulated expression of canonical histone 
proteins, histone variants and histone chaperones, in 
addition to chromatin-associated epigenetic regulatory 
factors, emphasizes the relevance of protecting genomic 
as well as epigenomic integrity to prevent malignant 
tumor development [72, 73]. Whereas knowledge on 
regulation of KMT expression and/or activity under 
hypoxic conditions is limited, expression of a number of 
KDMs is known to be mediated by HIF1A [50, 74–77]. 
Dysregulated expression of KMTs and KDMs is known to 
correlate with tumor cell survival, growth and increased 
malignancy [78–92]. Combined these observations sug-
gest the existence of dynamic feedback mechanisms 
among these factors that generate favorable tumor sur-
vival responses and microenvironmental conditions. 
Our study adds another level of epigenetic involvement 
in tumor biology to these observations: local and global 
chromatin modification in response to changes in the 
hypoxic tumor microenvironment. This aspect of tumor 
physiology is likely to affect a substantially larger cohort 




All animal experiments were approved by the local ethi-
cal committee from (Maastricht University; DEC license 
2012-107). The murine invasive lobular breast carcinoma 
cell line Kep1.11 was injected into the mammary fat path 
of NMRI-nu mice. When tumors reached an average vol-
ume of ±250  mm3, animals were injected with pimoni-
dazole (60 mg/kg i.p.) 1 h prior to killing. Tumors were 
excised and snap-frozen for histological analysis. Con-
secutive 5-μm sections were air-dried, acetone-fixed 
and rehydrated using PBS-Tween (0.2%) before blocking 
(30 min) with normal goat serum (5%). Slides were incu-
bated for 30 min with rabbit anti-pimonidazole (Hypoxy-
probe-1, Bioconnect; 1:150), rabbit anti-H3K27me3 
(07-499, Millipore; 1:400) or rabbit anti-H3K4me3 
(Ab8580, Abcam; 1:400). This was immediately followed 
by incubation (30 min) with rat anti-mouse CD31 (clone 
MEC13.3, BD Biosciences; 1:500) in a humidified cham-
ber at 37 °C. After washing in PBS-Tween, sections were 
incubated with secondary antibodies (goat anti-rabbit 
IgG Alexa Fluor 594, 1:500 or goat anti-rat IgG Alexa 
Fluor 488, 1:750; Invitrogen) for 45 min at 37 °C, washed 
and mounted with fluorescent mounting medium (Dako-
Cytomation). Automated image acquisition was done 
using Micromanager 1.4 software for [93] and spinning 
disk confocal microscopy (Olympus BX51WI) equipped 
with a Hamamatsu EM-CCD C9100 digital camera, a 
motorized stage (Ludl Mac 2000) and a 10×  objective. 
Image stitching and thresholding was performed using 
ImageJ v1.49e software.
Cell culture
MCF7 (human mammary adenocarcinoma) and DU145 
(human prostate carcinoma) cells (ATCC) were cultured 
at 37  °C, 5% CO2, 100% humidity in Dulbecco’s modi-
fied Eagle medium–nutrient mixture F-12 (DMEM/F12 
1:1; MCF7) and DMEM McCoy’s 5A medium (DU145). 
The culture medium was supplemented with 10% fetal 
calf serum (FCS), 200  mM  l-glutamine and antibiotics. 
For hypoxic exposure, cells were transferred to a MACS 
VA500 microaerophilic workstation (Don Whitley Scien-
tific, Shipley, UK) for the indicated duration. The atmos-
phere in the chamber consisted of <0.02% O2, 5% H2, 
5% CO2 and residual N2. For reoxygenation, cells were 
transferred back to the regular tissue culture incubator at 
ambient oxygen levels (21%). In some experimental con-
ditions cells were exposed to EZH2 inhibitors 5 µM UCN-
1999 (source) or 5 µM GSK343 (source); both inhibitors 
were dissolved in DMSO. Repeated oxygen deprivation/
reoxygenation was achieved using equipment and soft-
ware developed by the Engineering Department (Instru-
ments Development, Engineering and Evaluation) of 
Maastricht University Medical Centre, as previously 
described [94]. Briefly, MCF7 cells were seeded in 10-cm 
dishes (5  ×  105 cells/cm2) and exposed in triplicate to 
cycles of normoxia/hypoxia (6 or 18 cycles; 1 h 21% O2 
alternated by 1 h <0.02% O2); cycling was preceded and 
ended by an 8-h <0.02% O2 exposure. The atmosphere in 
the chambers always contained 5% CO2 and residual N2. 
After exposure, cells were processed for RNA isolation as 
described below.
Protein isolation and immunoblotting
Cells were grown to approximately 70% confluence 
before they were transferred to the hypoxic chamber. 
For protein extraction cells were washed twice with cold 
PBS and lysed in RIPA buffer (150 mM NaCl, 1% NP-40, 
0.5% w/v sodium deoxycholate, 0.1% SDS, 50  mM Tris 
at pH 8.0, 5  mM EDTA) supplemented with protease 
and phosphatase inhibitors (5  mM benzamidine, 5  µg/
ml antipain, 5 µg/ml leupeptin, 5 µg/µl aprotinin, 1 mM 
sodium vanadate, 10  mM sodium fluoride, 10  mM 
pyrophosphate, 10  mM ß-glycerophosphate, 0.5  mM 
DTT and 1  mM PMSF). Lysates were subjected to two 
freeze–thaw cycles in liquid nitrogen, followed by soni-
cation on ice with a probe sonicator (Soniprep 150; MSE, 
London, UK) for 12 cycles (1 s ON, 1 s OFF) with ampli-
tude 5. After 10-min centrifugation at 13.200 rpm (4 °C), 
the supernatant was transferred to a fresh tube and pro-
tein concentration was determined using a BCA protein 
assay kit (Pierce/Thermo Fisher Scientific, Rockford, 
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IL, USA) according to the manufacturers’ protocols on 
a Benchmark 550 Micro-plate Reader (Bio-Rad). For 
immunoblotting (IB) equal amounts of protein were 
boiled in Laemmli buffer for 5 min and loaded on 9–15% 
polyacrylamide gels. Following separation by SDS-
PAGE, proteins were transferred onto polyvinylidene 
fluoride (PVDF) membranes (GE Healthcare). Ponceau 
S (Sigma) staining was used to check protein transfer. 
Subsequently, PVDF membranes were blocked with 
3.4% nonfat dry milk (Protifar; Nutricia, Zoetermeer, the 
Netherlands) in PBS containing 0.1% Tween 20 (pH 7.5) 
for 1 h at RT, followed by an overnight incubation at 4 °C 
with the primary antibody (see Additional file  2: Table 
S2). Antibodies used include: anti-H3, anti-H3K4me3, 
anti-JMJD3 and anti-bTubulin (ab1791, Ab8580, 
ab85392, ab6046; Abcam, Cambridge, UK), H3K27me3 
(07-449; Upstate Biotechnology/Millipore, Waltham, 
MA, USA), anti-EZH2 (courtesy A. Bracken [45]), anti-
MLL1, anti-MLL4 and anti-SETD1A (A300-374A, A300-
113A, A300-289A; Bethyl Laboratories), anti-HIF1A 
(Clone 54; BD Bioscience), anti-CA9 (M75; courtesy S. 
Pastorekova [95]), anti-aTubulin (T6074; Sigma) and 
b-Actin (C4, 69100; MP Biomedicals, Solon, OH, USA). 
After extensive washing with PBS/0.2% Tween 20, bound 
antibodies were visualized with corresponding horserad-
ish peroxidase-conjugated secondary antibodies (1  h at 
RT): rat anti-mouse (DAKO, Glostrup, Denmark) and 
donkey-anti-rabbit (Jackson Lab, Bar Harbor, ME, USA) 
or by using IRDye 800CW or 670RD secondary antibod-
ies (LI-COR). Signals were detected on autoradiograms 
using enhanced chemoluminescence (ECL; Pierce). 
Immunoblots were imaged and quantified using Quan-
tity One software (Bio-Rad) or the Odyssey CLx imaging 
system (LI-COR) and ImageStudio Lite v.5.2.5 (LI-COR). 
Plots were generated using GraphPad Prism, version 
4.03, for Windows (GraphPad Software, San Diego, 
CA, USA). Data were statistically analyzed by perform-
ing two-tailed paired t tests using Microsoft Excel. Data 
given are expressed as mean ±  standard deviation (SD) 
and considered significant at p < 0.05. *, ** and *** indi-
cate p < 0.05, 0.01 and 0.001, respectively.
In vitro KDM assay
KDM6B (JMJD3) activity was measured using the JMJD3 
Chemiluminescent Assay Kit (Tebu-Bio, The Nether-
lands) according to the manufacturers’ instructions. 
Application of 25–100  ng recombinant KDM6B protein 
produced a dose-dependent response; the assay was per-
formed with 50  ng recombinant protein. Briefly, 8-well 
strips, precoated with methylated histone H3 peptides, 
were hydrated and incubated with recombinant KDM6B 
for 1 h exactly. Upon washing with TBST (50 mM Tris, 
150  mM NaCl, 0.05% Tween 20), wells were incubated 
with blocking buffer for 10  min. This first part of the 
assay was performed in an atmosphere with controlled 
oxygen levels using a MACS VA500 microaerophilic 
workstation (DW Scientific, UK). All solutions and mate-
rials were pre-equilibrated under the desired conditions. 
Incubation with ethylenediaminetetraacetic acid (EDTA, 
50 mM) provided a negative control. Detection of dem-
ethylated H3 substrate was carried out under atmos-
pheric oxygen concentration. Primary and HRP-labeled 
secondary antibodies (provided with the kit) were incu-
bated for 1 h and 30 min, respectively. A chemilumines-
cent signal was measured upon the addition of an HRP 
substrate.
Chromatin immunoprecipitation (ChIP) assays
MCF7 cells were transferred to hypoxic culturing condi-
tions for the indicated durations and immediately fixed 
in phosphate-buffered saline (PBS) containing 1% for-
maldehyde to avoid reoxygenation. Cross-linking was 
allowed to proceed for 10  min at room temperature 
and stopped by a 5-min incubation with glycine at a 
final concentration of 0.125 M. Fixed cells were washed 
twice with PBS and harvested in SDS buffer (50  mM 
Tris at pH 8.1, 0.5% SDS, 100 mM NaCl, 5 mM EDTA), 
supplemented with protease inhibitors (aprotinin, anti-
pain and leupeptin all at 5  µg/ml and 1  mM PMSF). 
Cells were pelleted by centrifugation and suspended in 
IP buffer (100 mM Tris at pH 8.6, 100 mM NaCl, 0.3% 
SDS, 1.7% Triton X-100, and 5  mM EDTA), containing 
protease inhibitors. Cells were disrupted by sonication, 
yielding genomic DNA fragments ranging from 200 to 
1000 base pairs, with a bulk size of 200–500 bp. For each 
immunoprecipitation 10–20 million cells were used. 
Approximately 1.2  ml of lysate was precleared by add-
ing of 35 µl of pretreated protein A beads; pretreatment: 
beads were washed six times in IP buffer and incubated 
in blocking solution (Protein A-Sepharose/CL-4B, GE 
Healthcare, Piscataway, NJ, USA); 0.5 mg/ml fatty acid-
free BSA, Sigma; and 0.2 mg/ml herring sperm DNA in 
TE (100 mM Tris at pH 8.1; 5 mM EDTA) for 60 min at 
4  °C, followed by centrifugation (3000 rpm, 60 s, 4  °C). 
Aliquots (12 µl) of precleared suspension were put aside 
as input (1/100th) DNA and kept at 4  °C. ChIPs were 
performed and analyzed as described previously with 
minor adjustments [45]. Samples were immunoprecipi-
tated overnight at 4  °C with primary antibodies. Anti-
bodies used include: anti-H3K4me3 (Ab8580; Abcam), 
anti-H3K27me3 (07-449; Upstate) and anti-HA (sc-805; 
Santa Cruz Biotechnology, Santa Cruz, CA, USA) as a 
negative controls. Immune complexes were recovered by 
adding 40 µl of blocked protein A beads (GE Healthcare) 
and incubated for 4 h at 4 °C. Beads were washed three 
times in 1 ml chilled mixed micelle buffer (20 mM Tris 
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at pH 8.1, 150 mM NaCl, 5 mM EDTA, 5% w/v sucrose, 
1% Triton X-100 and 0.2% SDS), twice in 1  ml chilled 
buffer 500 (50 mM HEPES at pH 7.5, 0.1% w/v sodium 
deoxycholate, 1% Triton X-100 and 1 mM EDTA), twice 
in 1 ml chilled LiCl detergent wash buffer (10 mM Tris at 
pH 8.0, 0.5% sodium deoxycholate, 0.5% NP-40, 250 mM 
LiCl and 1 mM EDTA), and once in 1 ml chilled TE. For 
sequential-ChIP (ChIP/reChIP), the primary precipitate 
was incubated for 30 min at 37 °C in 250 µl elution buffer 
(1% SDS, 0.1  M NaHCO3; under constant agitation) to 
elute protein/DNA complexes. Supernatants (30-s cen-
trifugation, maximum speed) were diluted in 3.2  ml IP 
buffer and incubated for 5  min (under constant agita-
tion; 4  °C); 100  µl per original IP sample was saved as 
input (1/10th); the remainder was split in three 1-ml 
aliquots and re-incubated with primary antibodies (e.g., 
anti-H3K4me3, anti-H3K27me3 or control) overnight, 
as described above. Pretreated protein A beads (20  µl) 
were added and incubated for 4  h (constant agitation, 
4 °C). Beads were collected by centrifugation (3000 rpm, 
60 s, 4 °C), washed in consecutive steps in mixed micelle 
buffer, buffer 500, LiCl detergent wash buffer and TE, 
as outlined above for the primary precipitates. Immune 
complexes were eluted for 2  h at 65  °C in 250  µl elu-
tion buffer under constant agitation at 1000  rpm, and 
supernatants were collected (30-s centrifugation, maxi-
mum speed). For PCR analysis, 250  µl elution buffer 
was added to input DNA samples and these were pro-
cessed in parallel with eluted samples. Cross-links were 
reversed overnight at 65 °C, followed by a 2-h digestion 
with RNAse A at 37 °C and 2 h proteinase K (0.2 µg/µl) at 
55  °C. DNA fragments were recovered using QIAquick 
PCR purification columns (Qiagen, Hilden, Germany), 
according to manufacturers’ instructions. Samples were 
eluted in 75  µl  EB, and the immunoprecipitated DNA 
was checked for enrichment using real-time PCR and 
quantified by fluorescence detection using Quant-iT™ 
Picogreen® dsDNA Reagent (Molecular Probers/Invit-
rogen, Eugene, OR, USA) before deep sequencing was 
applied. ChIP- and sequential-ChIP primers are listed in 
Additional file 2: Table S4.
Deep sequencing
Input and ChIP samples were further processed and 
sequenced at the Ontario Institute for Cancer Research 
using the Illumina next-generation sequencing plat-
form. Processing involved size selection to enrich for 
mononucleosome-sized fragments, linker annealing 
and PCR amplification. Each resulting library was sub-
sequently loaded onto  individual lanes of a flow cell 
and sequenced  using the 36-bp  paired-end protocol on 
the Illumina Genome Analyser IIx  (GAIIx). In order to 
obtain sufficient sequencing depth additional lanes were 
sequenced if necessary. All data obtained from each indi-
vidual sample were pooled.
Genome alignment, normalization, background correction; 
identification of enriched regions
Image processing and base calling were performed 
using Illumina software tools provided by the manu-
facturer. Subsequent paired-end genome alignment 
was performed using Novoalign with Human Genome 
18 (HG18) used as a reference genome. Only uniquely 
aligned reads were used for further analysis. To remove 
PCR artifacts all data were collapsed prior to peak call-
ing. To identify enriched regions in the ChIP samples 
relative to the input control, the peak caller Findpeaks 
(version 4.0) was used. For H3K4me3 the default settings 
were used, whereas for H3K27me3 the settings were 
adjusted in order to detect blanketing enrichment next 
to sharply defined peaks [43].
H3K27me3 is known to cover large chromo-
somal regions instead of sharp defined peaks [45, 46]. 
H3K27me3 data sets were normalized based on identi-
fication of regions with stable H3K27me3 enrichment 
between all samples analyzed, to enable quantitative 
comparisons. To this end we developed a standard-
ized protocol to define and summarize H3K27me3 
enrichment using deep-sequencing analysis. A detailed 
description of the protocol and the scripts used will be 
published elsewhere [43]. Briefly, so-called invariant 
regions were identified by calculating for each 20-Kb 
window in the genome the relative enrichment for high-
intensity H3K27me3 peaks (peak height >90th percen-
tile) using the ACME algorithm; 20-Kb regions enriched 
in all samples analyzed were defined as invariant, and 
neighboring invariant regions were merged. The cumu-
lative area under the curve for all peaks within these 
invariant regions was scaled relative to the smallest value 
among the samples. After normalization, a single cutoff 
value for all samples was set at the peak height) above 
which the H3K27me3 data correlate with the ChIP-seq 
data of a known H3K27me3-binding protein under nor-
moxic conditions (t =  0; data not shown). Peaks below 
this threshold were considered background noise (i.e., 
biologically irrelevant). To add further biological validity 
to this threshold, we defined a set of 1137 genes whose 
expression levels were above the 95th percentile for all 
samples analyzed, i.e., consistently highly expressed 
genes. Any repressive H3K27me3 marks present in 
these genes can be considered background noise, and 
indeed, for the vast majority of highly expressed genes 
H3K27me3 peaks were found to be below our calculated 
threshold.
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RNA isolation, gene expression microarray processing 
and analysis
For rtPCR analysis, total RNA was isolated using RNe-
asy minikit (Qiagen, Hilden, Germany) according to 
the manufacturers’ protocol. Quantity and quality of 
the RNA were determined by 260/280  and 260/230  nm 
absorbance measurements, respectively, using the Nan-
odrop (Witec AG, Luzern, Switzerland). Total RNA 
(0.5  µg) for each sample/replicate was converted into 
first-strand cDNA using the SensiFAST™ cDNA synthe-
sis kit (Bioline, London, UK) according to the manufac-
turers’ instructions. Gene expression was determined by 
rtPCR using the LightCycler® 480 (Roche Life Science, 
Penzberg, Germany) in combination with LightCycler® 
480 software (Roche Life Science); rtPCR was performed 
on 10  ng cDNA using the qPCR SensiMix™ SYBR and 
Fluorescein kit (Bioline) and 37.5  nM primer in 384-
well plates (Roche Life Science). For each primer pair a 
standard curve was generated with a serial dilution of a 
cDNA pool; rtPCR data were analyzed according to the 
LinRegPCR method. All values were normalized to beta-
actin and cyclophilin A; the control condition was used as 
a reference (set to 1). Primer sets for the selected genes 
were developed with Primer Express version 2.0 (Applied 
Biosystems, Foster City, CA, USA) using default settings 
(Additional file 2: Table S5).
RNA for microarray application was isolated using 
RNeasy minikit (Qiagen, Hilden, Germany) according 
to manufacturer’s protocol. Isolations were performed 
in triplicate. Total RNA samples were analyzed using the 
Affymetrix expression array platform (Affymetrix Gene 
Chip 1.0 ST). After scanning, data preprocessing and 
data analysis were done with R (http://www.R-project.
org; version 2.15) using Bioconductor (http://www.bio-
conductor.org; version 2.11). Data were background-cor-
rected using gcRMA [96] and normalized using GRSN 
rank-invariant normalization [97]. Updated Ensembl-
based probe set annotation was used from Brain Array 
(http://brainarray.mbni.med.umich.edu/brainarray/). The 
expression level of an individual gene was defined as the 
average of all probe sets representing this gene on the 
array. The lower detection threshold of gene expression 
was set at the maximum expression levels of Y chromo-
some genes (i.e., non-relevant in the context of female 
MCF7 cell line; log2-based expression value: 3.68). Genes 
were considered expressed well above background when 
expression exceeded 100 (non-log2 transformed expres-
sion units; log2-based expression value: ±6.64) for at least 
one independent time point. Statistical analysis of differ-
ential gene expression was performed using two ANOVA 
models: (1) a model for changes occurring under hypoxia 
(t = 0, t = 8 and t = 24; n = 3 for each time point) and 
(2) a model for changes occurring under reoxygenation 
(t = 24, t = +8 and t = 0 as putative endpoint; n = 3 for 
each time point). Acquired p values were corrected for 
multiple testing using the q value package in R. Genes 
were called significantly regulated if genes are expressed 
(>100 for 1 or more time points), the log2-based fold 
change between 2 independent time points is ≥2 and a 
corrected p value ≤0.05 for either the hypoxia model or 
reoxygenation model. Genes which were not represented 
on the microarray were not considered in the analyses.
Integration of microarray gene expression data 
and H3K27me3 and H3K4me3 ChIP‑seq data
The microarray gene expression data and the H3K27me3 
and H3K4me3 enrichment ChIP-seq data were integrated 
using the latest Ensembl genome annotation (HG18). 
For the identification of H3K27me3- and/or H3K4me3-
enriched genes, we defined a gene as the region between 
its 5′ (most upstream TSS) and 3′ (last exon) end plus 
5-kb regulatory regions up and downstream, respectively. 
A gene was called enriched or marked when there was 
at least one ChIP-seq peak above background level pre-
sent within this region as determined by the enrichment 
finding procedure. Gene Ontology enrichment analysis 
was performed using topGO [98, 99]. Comparative GO 
analysis with embryonal stem (ES) cell bivalent markers 
was based on published data [28]. Overlap of bivalently 
marked targets in MCF7 and in ES cells was determined 
by using the original reported data set of 332 bivalent 
genes [28] and independently by using a recent metaset 
of 2550 bivalent genes (consistent across multiple data 
sets; [49]). The data sets supporting the results of the cur-
rent study are available in the Gene Expression Omnibus 
(GEO) repository (http://www.ncbi.nlm.nih.gov/geo/) 
under accession number GSE71031 (subseries GSE70805 




All data visualization was carried out in R, including 
creation of histograms, gene tracks, genome plots, pie 
charts, TSS plots, boxplots, scatter plots. For the TSS 
peak intensity plots, all genes were considered in the 
same orientation (from 5′ to 3′ end), and the average peak 
intensity was depicted for a region defined in number of 
base pairs surrounding the TSS, as indicated. Boxplots 
show the 25th and 75th quartile (as indicated by the box), 
the median (indicated as a line within the box), and the 
whiskers indicate the 5 and 95% percentile, respectively. 
Notches in boxplots indicate 95% confidence intervals of 
the median. Differences between groups visualized in the 
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boxplots were tested using the nonparametric Wilcoxon 
signed-rank test, with significant differences (p  <  0.05) 
visually indicated in each.
H3K27me3 region‑specific profile analysis
To study region-specific enrichment profiles for 
H3K27me3, each gene was assigned to the promoter, 
the TSS or the Broad class, analogous to a previously 
published analysis [48]. To classify all genes, each gene 
was first divided into three regions: the promoter region 
[−3000/−100 base pairs (bp) in relation to the TSS], 
the TSS region (−100/1000  bp) and the broad region 
(+1000 bp to the last exon). Genes were allocated to the 
different classes based on which of the three regions con-
tained the largest amount of summarized enrichment 
(sum of normalized peak intensities within a region) 
scaled to the size of each region: Promoter class genes 
contain 25% more enrichment in the promoter region 
compared to the TSS and broad regions; TSS class genes 
contain 25% more enrichment in the TSS region com-
pared to the promoter and broad regions; and lastly, the 
Broad class genes contain peaks above background level 
in the broad region and are not TSS and Promoter class. 
Genes shorter than 4000  bp were excluded from the 
analysis, as they were too small to reliably assign them to 
either profile. Genes not meeting the above criteria were 
not considered for region-specific enrichment profile 
analysis.
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